Tag: Adriamycin
Articles
- BRCA1 and BRCA2 mutation carriers
- How to optimize your breast cancer diet
- Latest research concerning side effects of chemotherapy
- Latest research on factors influencing Adriamycin (doxorubicin) effectiveness
- What should BRCA1 and BRCA2 carriers, breast cancer patients and survivors eat?
- What should breast cancer patients eat during Adriamycin (doxorubicin) chemotherapy?
News
- Apigenin enhances the anticancer activity of 5-FU chemotherapy
- Bisphosphonates for treating osteoporosis may significantly reduce risk of breast cancer
- Black pepper may help prevent resistance to Adriamycin (doxorubicin) chemotherapy
- Caffeine may reduce the effectiveness of Adriamycin (doxorubicin) chemotherapy
- Chemotherapy resistance is accompanied by increase in number of breast cancer stem cells
- Curcumin reduces breast cancer resistance to treatment with Adriamycin (doxorubicin) chemotherapy
- Fasting protects normal cells and sensitizes cancer cells to chemotherapy
- Garlic reduces heart damage caused by doxorubicin chemotherapy
- Herceptin plus anthracycline chemotherapy greatly increases risk of heart damage
- Kaempferol protects against Adriamycin-induced heart damage
- Modern chemotherapy reduces breast cancer death by about a third compared to no chemotherapy
- Non-anthracycline chemotherapy plus Herceptin is effective treatment for HER2+ breast cancer
- Possible toxic side effects of chemotherapy
- Resveratrol increases effectiveness of Taxotere (docetaxel) and Adriamycin (doxorubicin)
- Taking Celebrex might reduce the effectiveness of chemotherapy for breast cancer
- The yellow vegetable pigment luteolin induces breast cancer cell death
- Turmeric component curcumin enhances effectiveness of Adriamycin chemotherapy
- Turmeric component curcumin inhibits breast cancer cell proliferation
- Very low circulating coenzyme Q10 (CoQ10) linked to increased breast cancer risk
Foods
Studies
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- Aged Garlic Extract Protects against Doxorubicin-Induced Cardiotoxicity In Rats
- Antitumor activity of doxorubicin is enhanced by curcumin
- Apigenin augments the growth inhibitory effects of doxorubicin in breast cancer cells derived from African American patients
- Attenuation of Cytotoxic Natural Product DNA Intercalating Agents by Caffeine
- BRCA2 deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure
- Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
- Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats
- Cardiotoxic Chemotherapy is Associated with Increased Heart Failure Risk Among Women with Breast Cancer in the Cancer Research Network
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
- Chemotherapeutic drug effects on spontaneous mobility and swimming endurance of mice
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
- Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats
- Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer
- Currying the Heart: Curcumin and Cardioprotection
- Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation
- Differential modulation of cisplatin and doxorubicin efficacies in leukemia cells by flavonoids
- Docosahexaenoic acid increases doxorubicin’s cytotoxicity against breast cancer cell lines
- Early identification of trastuzumab-related cardiotoxicity with speckle-tracking echocardiography
- Effects of doxorubicin on brain activity and resting-state functional connectivity in rats: fMRI studies
- Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin
- Endurance exercise protects cardiac tissue from doxorubicin-induced proteolysis and apoptosis
- Hematologic toxicity with adjuvant docetaxel and cyclophosphamide in early breast cancer
- Hepatotoxicity in breast cancer patients post-chemotherapy with docetaxel, doxorubucin, and cyclophosphamide
- Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice
- Influence of palm oil on doxorubicin induced cytotoxicity in normal and tumor cell cultures
- Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells
- Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro
- Late pancreatic toxicity in patients with breast cancer after taxane-anthracycline-based neoadjuvant and adjuvant chemotherapy
- Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells
- Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- Modulation by Melatonin of the Cardiotoxic and Antitumor Activities of Adriamycin
- New model system for testing effects of flavonoids on doxorubicin-related formation of hydroxyl radicals
- Pathology of late-onset anthracycline cardiomyopathy
- Patterns of Local and Distant Disease Relapse in Patients with Breast Cancer Treated with Primary Chemotherapy: Do Patients with a Complete Pathological Response Differ from Those with Residual Tumour in the Breast?
- Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells
- Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
- Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study
- Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
- Resveratrol enhances the sensitivity of doxorubicin-mediated cell proliferation, invasion, and migration in human breast cancer cell lines
- Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles
- Severe dietary restriction enhances cancer treatment: Protecting normal cells and sensitizing malignant cells to chemotherapy by fasting
- The effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts
- The herbal medicine black cohosh increases the cytotoxicity of doxorubicin to breast cancer cells by inhibiting doxorubicin efflux
- The Role of Curcuma longa Against Doxorubicin (Adriamycin)-Induced Toxicity in Rats
- Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
- Tumor infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer